Journal of Brain Research

Editor-in-Chief

KHUE VU NGUYEN, Scientist, Neurodevelopmental, Neurodegenerative Disorders University of California, USA, United States

About the Journal

Journal of Brain Research is a peer reviewed, open access journal considering research on all aspects of Neuroscience, Neurodegenerative diseases, Experimental neurology, Functional neurology, Traumatic Brain injury, surgical neurology, Neurological rehabilitation, Neurotoxicology, Neuropharmacology, Neuronal plasticity and Behaviour, clinical neurology, Brain development and Cell differentiation. The Journal aims to provide a platform for the exchange of scientific information addressing research topics in the field of Brain and Neurological sciences.

Journal of Brain Research accepts original manuscripts in the form of research articles, review articles, Clinical reviews, commentaries, case reports, perspectives and short communications encompassing all aspects of Neurological sciences.

This peer reviewed journal includes following topics but are not limited to: Neurobiology, Neuroscience, Neurodegenerative disorders, Neurosurgery, Behavioural plasticity, Developmental neurobiology, Aging and memory loss, Neurophysiology, Cerebral ischemia, Neuroinflammation, synaptic plasticity, Taurmatic Brain Injury, Spinal cord injury, Clinical neuroscience, Neuroimaging, cognitive neuroscience, Neuropsychopharmacology, Neuropathology. Contributions across the globe from all professions encompassing Researchers, Clinical Practitioner’s, Doctors and Students are therefore encouraged.

The editorial office of the journal promises a peer review process for the submitted manuscripts for the quality of publishing. All the manuscripts published by Journal of Brain Research are available freely online immediately after publication without any subscription charges or registration.

Submit manuscript at https://www.scholarscentral.org/submissions/brain-research.html or as an e-mail attachment to editor@hilarisjournal.com

Rapid Publication Service

Hilaris Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.

The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.

Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.

Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.

Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.

Recent Articles

• 

  Note on Chronic Traumatic Encephalopathy

  Markey Beauchamp*

  Commentary

• 

  Alcohol and Substance Abuse Evaluation

  Shalehuddin Zarrouk-Mahjoub*

  Short Communication

• 

  Note on Chronic Traumatic Encephalopathy

  Markey Beauchamp*

  Commentary

• 

  Alcohol and Substance Abuse Evaluation

  Shalehuddin Zarrouk-Mahjoub*

  Short Communication

• 

  Short Note on Mild Cognitive Impairment

  Melissa Haas*

  Commentary

• 

  Short Note on Mild Cognitive Impairment

  Melissa Haas*

  Commentary